{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:01:36Z","timestamp":1774634496698,"version":"3.50.1"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T00:00:00Z","timestamp":1300492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11095-011-0392-y","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T17:20:44Z","timestamp":1300468844000},"page":"1241-1258","source":"Crossref","is-referenced-by-count":52,"title":["Controlled Delivery Systems: From Pharmaceuticals to Cells and Genes"],"prefix":"10.1007","volume":"28","author":[{"given":"Elizabeth Rosado","family":"Balmayor","sequence":"first","affiliation":[]},{"given":"Helena Sepulveda","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Rui L.","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,19]]},"reference":[{"key":"392_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/JNN.0b013e318193458b","volume":"41","author":"AC Berkowitz","year":"2009","unstructured":"Berkowitz AC, Goddard DM. Novel drug delivery systems: future directions. J Neurosci Nurs. 2009;41:115\u201320.","journal-title":"J Neurosci Nurs"},{"key":"392_CR2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.copbio.2003.10.007","volume":"14","author":"G Orive","year":"2003","unstructured":"Orive G, Hern\u00e1ndez RM, Gasc\u00f3n AR, Dom\u00ednguez-Gil A, Pedraz JL. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol. 2003;14:659\u201364.","journal-title":"Curr Opin Biotechnol"},{"key":"392_CR3","first-page":"437","volume-title":"Encyclopedia of medical devices and instrumentation","author":"D Paolino","year":"2006","unstructured":"Paolino D, Fresta M, Sinha P, Ferrari M. Drug Delivery Systems. In: Webster JG, editor. Encyclopedia of medical devices and instrumentation. New York: Wiley; 2006. p. 437\u201395."},{"key":"392_CR4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.actbio.2008.11.006","volume":"5","author":"ER Balmayor","year":"2009","unstructured":"Balmayor ER, Tuzlakoglu K, Azevedo HS, Reis RL. Preparation and characterization of starch-poly-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications. Acta Biomater. 2009;5:1035\u201345.","journal-title":"Acta Biomater"},{"key":"392_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.addr.2007.03.012","volume":"59","author":"PB Malafaya","year":"2007","unstructured":"Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 2007;59:207\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"392_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2008.08.005","volume":"132","author":"E Wenk","year":"2008","unstructured":"Wenk E, Wandrey AJ, Merkle HP, Meinel L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release. 2008;132:26\u201334.","journal-title":"J Control Release"},{"key":"392_CR7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/j.1552-4604.1990.tb03566.x","volume":"30","author":"W Ranade","year":"1990","unstructured":"Ranade W. Drug delivery systems. Implants in drug delivery. J Clin Pharmacol. 1990;30:871\u201389.","journal-title":"J Clin Pharmacol"},{"key":"392_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/088532829400800305","volume":"8","author":"MJ Nitsch","year":"1994","unstructured":"Nitsch MJ, Banakar UV. Implantable drug delivery. J Biomater Appl. 1994;8:247\u201384.","journal-title":"J Biomater Appl"},{"key":"392_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/156720108783331041","volume":"5","author":"DP Pioletti","year":"2008","unstructured":"Pioletti DP, Gauthier O, Stadelmann VA, Bujoli B, Guicheux J, Zambelli PY, et al. Orthopedic implant used as drug delivery system: clinical situation and state of the research. Curr Drug Deliv. 2008;5:59\u201363.","journal-title":"Curr Drug Deliv"},{"key":"392_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/17434440.4.1.55","volume":"4","author":"J Parvizi","year":"2007","unstructured":"Parvizi J, Antoci V, Hickok NJ, Shapiro IM. Selfprotective smart orthopedic implants. Expert Rev Med Devices. 2007;4:55\u201364.","journal-title":"Expert Rev Med Devices"},{"key":"392_CR11","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/aic.690491202","volume":"49","author":"R Langer","year":"2003","unstructured":"Langer R, Peppas NA. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 2003;49:2990\u20133006.","journal-title":"AIChE J"},{"key":"392_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd1721","volume":"4","author":"H Rosen","year":"2005","unstructured":"Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov. 2005;4:381\u20135.","journal-title":"Nat Rev Drug Discov"},{"key":"392_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-6147(98)01196-1","volume":"19","author":"KK Jain","year":"1998","unstructured":"Jain KK. Strategies and technologies for drug delivery systems. Trends Pharmacol Sci. 1998;19:155\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2004.05.006","volume":"25","author":"G Orive","year":"2004","unstructured":"Orive G, Gascon AR, Hernandez RM, Dominguez-Gil A, Pedraz JL. Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol Sci. 2004;25:382\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2008.08.032","volume":"364","author":"A Arora","year":"2008","unstructured":"Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm. 2008;364:227\u201336.","journal-title":"Int J Pharm"},{"key":"392_CR16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261\u20138.","journal-title":"Nat Biotechnol"},{"key":"392_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","volume":"3","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"392_CR18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/mi.4.6.1","volume":"4","author":"S Scheindlin","year":"2004","unstructured":"Scheindlin S. Transdermal drug delivery: past, present, future. Mol Interv. 2004;4:308\u201312.","journal-title":"Mol Interv"},{"key":"392_CR19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1461-5347(99)00238-2","volume":"3","author":"VD Vilivalam","year":"2000","unstructured":"Vilivalam VD, Illum L, Iqbal K. Starch capsules: an alternative system for oral drug delivery. Pharm Sci Technolo Today. 2000;3:64\u20139.","journal-title":"Pharm Sci Technolo Today"},{"key":"392_CR20","first-page":"9","volume":"4","author":"S Majuru","year":"2004","unstructured":"Majuru S. Advances in the oral delivery of heparin from solid dosage forms using emisphere\u2019s eligen\u00ae oral drug delivery technology. Drug Deliv Technol. 2004;4:9\u201314.","journal-title":"Drug Deliv Technol"},{"key":"392_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(02)00024-8","volume":"237","author":"EA Hosny","year":"2002","unstructured":"Hosny EA, Al-Shora HI, Elmazar MM. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. Int J Pharm. 2002;237:71\u20136.","journal-title":"Int J Pharm"},{"key":"392_CR22","unstructured":"Rosenblatt JS, Berg RA. Collagen-based injectable drug delivery system and its use. 1998. US Patent Specification 5807581. United State"},{"key":"392_CR23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17425247.5.9.1047","volume":"5","author":"G Bernstein","year":"2008","unstructured":"Bernstein G. Delivery of insulin to the buccal mucosa utilizing the RapidMist\u2122 system. Expert Opin Drug Deliv. 2008;5:1047\u201355.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1517\/17425247.2.4.625","volume":"2","author":"P Rogueda","year":"2005","unstructured":"Rogueda P. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opin Drug Deliv. 2005;2:625\u201338.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR25","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/jps.21380","volume":"97","author":"JZ Yang","year":"2008","unstructured":"Yang JZ, Young AL, Chiang P-C, Thurston A, Pretzer DK. Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies. J Pharm Sci. 2008;97:4869\u201378.","journal-title":"J Pharm Sci"},{"key":"392_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-008-9707-z","volume":"26","author":"JD Engstrom","year":"2008","unstructured":"Engstrom JD, Tam JM, Miller MA, Williams RO, Johnston KP. Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers. Pharm Res. 2008;26:101\u201317.","journal-title":"Pharm Res"},{"key":"392_CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603\u201318.","journal-title":"Adv Drug Deliv Rev"},{"key":"392_CR28","first-page":"4","volume-title":"Percutaneous penetration enhancers","author":"EW Smith","year":"2006","unstructured":"Smith EW, Maibach HI. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. Boca Raton: CRC Press. Taylor & Francis Group; 2006. p. 4\u201314."},{"key":"392_CR29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jps.10160","volume":"91","author":"HK Vaddi","year":"2002","unstructured":"Vaddi HK, Ho PC, Chan SY. Terpenes in propylene glycol as skin-penetration enhancers: Permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci. 2002;91:1639\u201351.","journal-title":"J Pharm Sci"},{"key":"392_CR30","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/jps.10164","volume":"91","author":"H Tang","year":"2002","unstructured":"Tang H, Blankschtein D, Langer R. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: Comparative studies with in vivo and in vitro skin. J Pharm Sci. 2002;91:1776\u201394.","journal-title":"J Pharm Sci"},{"key":"392_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.bioeng.2.1.289","volume":"2","author":"DV McAllister","year":"2000","unstructured":"McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng. 2000;2:289\u2013313.","journal-title":"Annu Rev Biomed Eng"},{"key":"392_CR32","doi-asserted-by":"crossref","first-page":"13755","DOI":"10.1073\/pnas.2331316100","volume":"100","author":"DV McAllister","year":"2003","unstructured":"McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA. 2003;100:13755\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"392_CR33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","volume":"87","author":"S Henry","year":"1998","unstructured":"Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87:922\u20135.","journal-title":"J Pharm Sci"},{"key":"392_CR34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1023\/A:1013395102049","volume":"18","author":"W Lin","year":"2001","unstructured":"Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng CL, et al. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res. 2001;18:1789\u201393.","journal-title":"Pharm Res"},{"key":"392_CR35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1023\/B:PHAM.0000029282.44140.2e","volume":"21","author":"W Martanto","year":"2004","unstructured":"Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR. Transdermal delivery of insulin using microneedles in vivo. Pharm Res. 2004;21:947\u201352.","journal-title":"Pharm Res"},{"key":"392_CR36","first-page":"589","volume-title":"Modified-release drug delivery technology","author":"M Cormier","year":"2003","unstructured":"Cormier M, Daddona PE. Macroflux technology for transdermal delivery of therapeutic proteins and vaccines. In: Rathbone MJ, Hadgraft J, Roberts MS, editors. Modified-release drug delivery technology. New York: Marcel Dekker, Inc.; 2003. p. 589\u201398."},{"key":"392_CR37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1213\/00000539-200102000-00041","volume":"92","author":"S Kaushik","year":"2001","unstructured":"Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg. 2001;92:502\u20134.","journal-title":"Anesth Analg"},{"key":"392_CR38","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1016\/j.vaccine.2007.10.020","volume":"25","author":"PE Laurent","year":"2007","unstructured":"Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007;25:8833\u201342.","journal-title":"Vaccine"},{"key":"392_CR39","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1073\/pnas.0710355105","volume":"105","author":"DP Wermeling","year":"2008","unstructured":"Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA. 2008;105:2058\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"392_CR40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/hv.1.3.1797","volume":"1","author":"CH Dean","year":"2005","unstructured":"Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005;1:106\u201311.","journal-title":"Hum Vaccin"},{"key":"392_CR41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/17425247.2.5.791","volume":"2","author":"G Mutwiri","year":"2005","unstructured":"Mutwiri G, Bowersock TL, Babiuk LA. Microparticles for oral delivery of vaccines. Expert Opin Drug Deliv. 2005;2:791\u2013806.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","volume":"3","author":"EC Lavelle","year":"2006","unstructured":"Lavelle EC, O\u2019Hagan DT. Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv. 2006;3:747\u201362.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/17425247.2.5.855","volume":"2","author":"A Maroni","year":"2005","unstructured":"Maroni A, Zema L, Cerea M, Sangalli ME. Oral pulsatile drug delivery systems. Expert Opin Drug Deliv. 2005;2:855\u201371.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3109\/03639049809108573","volume":"24","author":"CT Rhodes","year":"1998","unstructured":"Rhodes CT, Porter SC. Coatings for controlled release drug delivery systems. Drug Dev Ind Pharm. 1998;24:1139\u201354.","journal-title":"Drug Dev Ind Pharm"},{"key":"392_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14712598.2.1.67","volume":"2","author":"I Lambkin","year":"2002","unstructured":"Lambkin I, Pinilla C. Targeting approaches to oral drug delivery. Expert Opin Biol Ther. 2002;2:67\u201373.","journal-title":"Expert Opin Biol Ther"},{"key":"392_CR46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/10611869509015943","volume":"3","author":"NA Peppas","year":"1995","unstructured":"Peppas NA, Robinson JR. Bioadhesives for optimization of drug delivery. J Drug Target. 1995;3:183\u20134.","journal-title":"J Drug Target"},{"key":"392_CR47","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/17425240802567846","volume":"5","author":"EA Simone","year":"2008","unstructured":"Simone EA, Dziubla TD, Muzykantov VR. Polymeric carriers: role of geometry in drug delivery. Expert Opin Drug Deliv. 2008;5:1283\u2013300.","journal-title":"Expert Opin Drug Deliv"},{"key":"392_CR48","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0022-5347(05)68810-6","volume":"161","author":"RU Anderson","year":"1999","unstructured":"Anderson RU, Mobley D, Blank B, Saltzstein D, Susset J, Brown JS. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J Urol. 1999;161:1809\u201312.","journal-title":"J Urol"},{"key":"392_CR49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0029-7844(99)00661-4","volume":"95","author":"E Versi","year":"2000","unstructured":"Versi E, Appell R, Mobley D, Patton W, Saltzstein D. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group. Obstet Gynecol. 2000;95:718\u201321.","journal-title":"Obstet Gynecol"},{"key":"392_CR50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archpsyc.60.2.204","volume":"60","author":"J Swanson","year":"2003","unstructured":"Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit\/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003;60:204\u201311.","journal-title":"Arch Gen Psychiatry"},{"key":"392_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0168-3659(93)90207-L","volume":"26","author":"U Conte","year":"1993","unstructured":"Conte U, Maggi L, Colombo P, Lamanna A. Multilayered hydrophilic matrices as constant release devices (Geomatrix(Tm) Systems). J Control Release. 1993;26:39\u201347.","journal-title":"J Control Release"},{"key":"392_CR52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0142-9612(96)83284-4","volume":"17","author":"U Conte","year":"1996","unstructured":"Conte U, Maggi L. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 1996;17:889\u201396.","journal-title":"Biomaterials"},{"key":"392_CR53","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","volume":"14","author":"Y Ozsoy","year":"2009","unstructured":"Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules. 2009;14:3754\u201379.","journal-title":"Molecules"},{"key":"392_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10717540490280750","volume":"11","author":"SK Jain","year":"2004","unstructured":"Jain SK, Chourasia MK, Jain AK, Jain RK, Shrivastava AK. Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv. 2004;11:113\u201322.","journal-title":"Drug Deliv"},{"key":"392_CR55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/03639040903517906","volume":"36","author":"S Gungor","year":"2010","unstructured":"Gungor S, Okyar A, Erturk-Toker S, Baktir G, Ozsoy Y. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes. Drug Dev Ind Pharm. 2010;36:806\u201313.","journal-title":"Drug Dev Ind Pharm"},{"key":"392_CR56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/js950534b","volume":"85","author":"T Loftsson","year":"1996","unstructured":"Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017\u201325.","journal-title":"J Pharm Sci"},{"key":"392_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","volume":"36","author":"FWHM Merkus","year":"1999","unstructured":"Merkus FWHM, Verhoef JC, Marttin E, Romeijn SG, van der Kuy PHM, Hermens WAJJ, et al. Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev. 1999;36:41\u201357.","journal-title":"Adv Drug Deliv Rev"},{"key":"392_CR58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1185\/030079906X167381","volume":"23","author":"RP Hayes","year":"2007","unstructured":"Hayes RP, Muchmore D, Schmitke J. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes. Curr Med Res Opin. 2007;23:435\u201342.","journal-title":"Curr Med Res Opin"},{"key":"392_CR59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CPP42456","volume":"42","author":"B Otulana","year":"2004","unstructured":"Otulana B, Okikawa J, Linn L, Morishige R, Thipphawong J. Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma. Int J Clin Pharmacol Ther Toxicol. 2004;42:456\u201362.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"392_CR60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0091270004269840","volume":"45","author":"S Davison","year":"2005","unstructured":"Davison S, Thipphawong J, Blanchard J, Liu K, Morishige R, Gonda I, et al. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. J Clin Pharmacol. 2005;45:177\u201384.","journal-title":"J Clin Pharmacol"},{"key":"392_CR61","first-page":"632","volume":"60","author":"RG Jiang","year":"2005","unstructured":"Jiang RG, Pan WS, Wang CL, Liu H. Use of recrystallized lactose as carrier for inhalation powder of interferon a2b. Pharmazie. 2005;60:632\u20133.","journal-title":"Pharmazie"},{"key":"392_CR62","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","volume":"49","author":"TR Hoare","year":"2008","unstructured":"Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymers. 2008;49:1993\u20132007.","journal-title":"Polymers"},{"key":"392_CR63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-0286(02)00077-3","volume":"6","author":"PB Malafaya","year":"2002","unstructured":"Malafaya PB, Silva GA, Baran ET, Reis RL. Drug delivery therapies II.: strategies for delivering bone regenerating factors. Curr Opin Solid State Mater Sci. 2002;6:297\u2013312.","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"392_CR64","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/cr000108x","volume":"101","author":"KY Lee","year":"2001","unstructured":"Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101:1869\u201379.","journal-title":"Chem Rev"},{"key":"392_CR65","unstructured":"Thompson I. Market trends: disposable mono-dose auto-injectors and pen-injectors. ONdrugDelivery. 2008;15\u201317."},{"key":"392_CR66","unstructured":"Young M. The next generation of auto-injectors. ONdrugDelivery. 2010:4\u20137."},{"key":"392_CR67","unstructured":"Dey-Pharma. EpiPen Autoinjector. www.dey.com ; www.epipen.com (accessed December 2010)."},{"key":"392_CR68","unstructured":"EMD Serono Inc. and Pfizer Inc. Rebif. www.rebif.com (accessed December 2010)."},{"key":"392_CR69","unstructured":"Amgen and Pfizer Inc. SureClick. www.enbrel.com (accessed December 2010)."},{"key":"392_CR70","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"BE Rabinow","year":"2004","unstructured":"Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"392_CR71","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1023\/A:1019829622088","volume":"19","author":"L Jia","year":"2002","unstructured":"Jia L, Wong H, Cerna C, Weitman SD. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography\/mass spectrometry. Pharm Res. 2002;19:1091\u20136.","journal-title":"Pharm Res"},{"key":"392_CR72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","volume":"125","author":"GG Liversidge","year":"1995","unstructured":"Liversidge GG, Cundy KC. Particle-size reduction for improvement of oral bioavailability of hydrophobic drugs.1. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 1995;125:91\u20137.","journal-title":"Int J Pharm"},{"key":"392_CR73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0378-5173(95)00148-C","volume":"125","author":"GG Liversidge","year":"1995","unstructured":"Liversidge GG, Conzentino P. Drug particle-size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm. 1995;125:309\u201313.","journal-title":"Int J Pharm"},{"key":"392_CR74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0091270003261490","volume":"44","author":"WK Kraft","year":"2004","unstructured":"Kraft WK, Steiger B, Beussink D, Quiring JN, Fitzgerald N, Greenberg HE, et al. The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J Clin Pharmacol. 2004;44:67\u201372.","journal-title":"J Clin Pharmacol"},{"key":"392_CR75","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","volume":"30","author":"Y Malam","year":"2009","unstructured":"Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30:592\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","volume":"2","author":"R Duncan","year":"2003","unstructured":"Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2:347\u201360.","journal-title":"Nat Rev Drug Discov"},{"key":"392_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-005-9046-2","volume":"23","author":"LY Qiu","year":"2006","unstructured":"Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res. 2006;23:1\u201330.","journal-title":"Pharm Res"},{"key":"392_CR78","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.biomaterials.2005.11.008","volume":"27","author":"KY Win","year":"2006","unstructured":"Win KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials. 2006;27:2285\u201391.","journal-title":"Biomaterials"},{"key":"392_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2006.12.017","volume":"67","author":"EC Gryparis","year":"2007","unstructured":"Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur J Pharm Biopharm. 2007;67:1\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"392_CR80","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.progpolymsci.2008.07.005","volume":"33","author":"AK Bajpai","year":"2008","unstructured":"Bajpai AK, Shukla SK, Bhanu S, Kankane S. Responsive polymers in controlled drug delivery. Prog Polym Sci. 2008;33:1088\u2013118.","journal-title":"Prog Polym Sci"},{"key":"392_CR81","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1016\/j.actbio.2010.07.018","volume":"6","author":"G Frutos","year":"2010","unstructured":"Frutos G, Prior-Cabanillas A, Par\u00eds R, Quijada-Garrido I. A novel controlled drug delivery system based on pH-responsive hydrogels included in soft gelatin capsules. Acta Biomater. 2010;6:4650\u20136.","journal-title":"Acta Biomater"},{"key":"392_CR82","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.carres.2007.07.007","volume":"342","author":"B-L Guo","year":"2007","unstructured":"Guo B-L, Gao Q-Y. Preparation and properties of a pH\/temperature-responsive carboxymethyl chitosan\/poly(N-isopropylacrylamide)semi-IPN hydrogel for oral delivery of drugs. Carbohydr Res. 2007;342:2416\u201322.","journal-title":"Carbohydr Res"},{"key":"392_CR83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2009.10.011","volume":"142","author":"R Suedee","year":"2010","unstructured":"Suedee R, Jantarat C, Lindner W, Viernstein H, Songkro S, Srichana T. Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs. J Control Release. 2010;142:122\u201331.","journal-title":"J Control Release"},{"key":"392_CR84","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1016\/j.biomaterials.2003.12.032","volume":"25","author":"K Zhang","year":"2004","unstructured":"Zhang K, Wu XYXY. Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides. Biomaterials. 2004;25:5281\u201391.","journal-title":"Biomaterials"},{"key":"392_CR85","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2006.06.017","volume":"114","author":"T Niidome","year":"2006","unstructured":"Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release. 2006;114:343\u20137.","journal-title":"J Control Release"},{"key":"392_CR86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1369-7021(09)70157-9","volume":"12","author":"H Li","year":"2009","unstructured":"Li H, Carter JD, LaBean TH. Nanofabrication by DNA self-assembly. Mater Today. 2009;12:24\u201332.","journal-title":"Mater Today"},{"key":"392_CR87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1369-7021(09)70156-7","volume":"12","author":"GA Ozin","year":"2009","unstructured":"Ozin GA, Hou K, Lotsch BV, Cademartiri L, Puzzo DP, Scotognella F, et al. Nanofabrication by self-assembly. Mater Today. 2009;12:12\u201323.","journal-title":"Mater Today"},{"key":"392_CR88","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","volume":"60","author":"JD Byrne","year":"2008","unstructured":"Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60:1615\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"392_CR89","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1557\/mrs2006.209","volume":"31","author":"P Shah","year":"2006","unstructured":"Shah P. Use of nanotechnologies for drug delivery. MRS Bull. 2006;31:894\u20139.","journal-title":"MRS Bull"},{"key":"392_CR90","first-page":"32","volume":"18","author":"LR Kaiser","year":"1992","unstructured":"Kaiser LR. The future of multihospital systems. Top Health Care Financ. 1992;18:32\u201345.","journal-title":"Top Health Care Financ"},{"key":"392_CR91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tips.2007.10.010","volume":"29","author":"E Anitua","year":"2008","unstructured":"Anitua E, Sanchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci. 2008;29:37\u201341.","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR92","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","volume":"83","author":"S Werner","year":"2003","unstructured":"Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835\u201370.","journal-title":"Physiol Rev"},{"key":"392_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/term.63","volume":"2","author":"PC Bessa","year":"2008","unstructured":"Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med. 2008;2:1\u201313.","journal-title":"J Tissue Eng Regen Med"},{"key":"392_CR94","unstructured":"Wound Biotechnology, Department of Dermatology, School of Medicine, Boston University. Growth factors: their development and testing. http:\/\/www.bu.edu\/woundbiotech\/growthfactors\/gfdevtest.html (accessed January 2011)."},{"key":"392_CR95","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cytogfr.2009.10.001","volume":"20","author":"MH Alaoui-Ismaili","year":"2009","unstructured":"Alaoui-Ismaili MH, Falb D. Design of second generation therapeutic recombinant bone morphogenetic proteins. Cytokine Growth Factor Rev. 2009;20:501\u20137.","journal-title":"Cytokine Growth Factor Rev"},{"key":"392_CR96","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1302\/0301-620X.84B2.11167","volume":"84","author":"LA Fortier","year":"2002","unstructured":"Fortier LA, Mohammed HO, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg. 2002;84:276\u201388.","journal-title":"J Bone Joint Surg"},{"key":"392_CR97","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1538-7836.2007.02386.x","volume":"5","author":"EA Silva","year":"2007","unstructured":"Silva EA, Mooney DJ. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost. 2007;5:590\u20138.","journal-title":"J Thromb Haemost"},{"key":"392_CR98","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11095-006-9173-4","volume":"24","author":"RR Chen","year":"2007","unstructured":"Chen RR, Silva EA, Yuen WW, Mooney DJ. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 2007;24:258\u201364.","journal-title":"Pharm Res"},{"key":"392_CR99","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S8756-3282(03)00207-2","volume":"33","author":"L Meinel","year":"2003","unstructured":"Meinel L, Zoidis E, Zapf J, Hassa P, Hottiger MO, Auer JA, et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone. 2003;33:660\u201372.","journal-title":"Bone"},{"key":"392_CR100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bone.2008.06.019","volume":"43","author":"ZS Patel","year":"2008","unstructured":"Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone. 2008;43:931\u201340.","journal-title":"Bone"},{"key":"392_CR101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(03)00258-X","volume":"91","author":"TA Holland","year":"2003","unstructured":"Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release. 2003;91:299\u2013313.","journal-title":"J Control Release"},{"key":"392_CR102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature02388","volume":"428","author":"R Langer","year":"2004","unstructured":"Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004;428:487\u201392.","journal-title":"Nature"},{"key":"392_CR103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-6147(03)00073-7","volume":"24","author":"G Orive","year":"2003","unstructured":"Orive G, Gascon AR, Hernandez RM, Igartua M, Pedraz JL. Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharmacol Sci. 2003;24:207\u201310.","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR104","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0167-7799(02)02037-1","volume":"20","author":"G Orive","year":"2002","unstructured":"Orive G, Hernandez RM, Gascon AR, Igartua M, Pedraz JL. Encapsulated cell technology: from research to market. Trends Biotechnol. 2002;20:382\u20137.","journal-title":"Trends Biotechnol"},{"key":"392_CR105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tibtech.2003.11.004","volume":"22","author":"G Orive","year":"2004","unstructured":"Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TMS, de Vos P, et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 2004;22:87\u201392.","journal-title":"Trends Biotechnol"},{"key":"392_CR106","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2008.08.010","volume":"132","author":"A Murua","year":"2008","unstructured":"Murua A, Portero A, Orive G, Hernandez RM, de Castro M, Pedraz JL. Cell microencapsulation technology: towards clinical application. J Control Release. 2008;132:76\u201383.","journal-title":"J Control Release"},{"key":"392_CR107","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/187152206776359948","volume":"6","author":"P Vos de","year":"2006","unstructured":"de Vos P, Andersson A, Tam SK, Faas MM, Hall\u00e9 JP. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immunol Endocr Metab Agents Med Chem. 2006;6:139\u201353.","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"392_CR108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bej.2006.02.003","volume":"30","author":"S Sakai","year":"2006","unstructured":"Sakai S, Hashimoto I, Kawakami K. Development of alginate-agarose subsievesize capsules for subsequent modification with a polyelectrolyte complex membrane. Biochem Eng J. 2006;30:76\u201381.","journal-title":"Biochem Eng J"},{"key":"392_CR109","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bip.20509","volume":"82","author":"L Baruch","year":"2006","unstructured":"Baruch L, Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers. 2006;82:570\u20139.","journal-title":"Biopolymers"},{"key":"392_CR110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/bit.21452","volume":"98","author":"TJ Wu","year":"2007","unstructured":"Wu TJ, Huang HH, Hsu YM, Lyu SR, Wang YJ. A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers. Biotechnol Bioeng. 2007;98:578\u201385.","journal-title":"Biotechnol Bioeng"},{"key":"392_CR111","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1089\/ten.2006.12.2665","volume":"12","author":"C Chung","year":"2006","unstructured":"Chung C, Mesa J, Miller GJ, Randolph MA, Gill TJ, Burdick JA. Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. Tissue Eng. 2006;12:2665\u201373.","journal-title":"Tissue Eng"},{"key":"392_CR112","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.biomaterials.2007.01.021","volume":"28","author":"LS Ferreira","year":"2007","unstructured":"Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials. 2007;28:2706\u201317.","journal-title":"Biomaterials"},{"key":"392_CR113","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2005.11.180","volume":"340","author":"SP Black","year":"2006","unstructured":"Black SP, Constantinidis I, Cui H, Tucker-Burden C, Weber CJ, Safley SA. Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice. Biochem Biophys Res Commun. 2006;340:236\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"392_CR114","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/01.tp.0000208610.75997.20","volume":"81","author":"D Dufrane","year":"2006","unstructured":"Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation. 2006;81:1345\u201353.","journal-title":"Transplantation"},{"key":"392_CR115","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.transproceed.2006.03.014","volume":"38","author":"R Calafiore","year":"2006","unstructured":"Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, et al. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc. 2006;38:1156\u20137.","journal-title":"Transplant Proc"},{"key":"392_CR116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diacare.29.01.06.dc05-1270","volume":"29","author":"R Calafiore","year":"2006","unstructured":"Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes - First two cases. Diab Care. 2006;29:137\u20138.","journal-title":"Diab Care"},{"key":"392_CR117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actbio.2006.06.007","volume":"3","author":"Y Hong","year":"2007","unstructured":"Hong Y, Song HQ, Gong YH, Mao ZW, Gao CY, Shen JC. Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation. Acta Biomater. 2007;3:23\u201331.","journal-title":"Acta Biomater"},{"key":"392_CR118","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jbm.a.31213","volume":"82A","author":"B Inanc","year":"2007","unstructured":"Inanc B, Elcin AE, Koc A, Balos K, Parlar A, Elcin YM. Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. J Biomed Mater Res A. 2007;82A:917\u201326.","journal-title":"J Biomed Mater Res A"},{"key":"392_CR119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/bit.21624","volume":"99","author":"S Sakai","year":"2008","unstructured":"Sakai S, Hashimoto I, Kawakami K. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules. Biotechnol Bioeng. 2008;99:235\u201343.","journal-title":"Biotechnol Bioeng"},{"key":"392_CR120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10529-007-9312-y","volume":"29","author":"S Sakai","year":"2007","unstructured":"Sakai S, Hashimoto I, Kawakami K. Agarose-gelatin conjugate for adherent cell-enclosing capsules. Biotechnol Lett. 2007;29:731\u20135.","journal-title":"Biotechnol Lett"},{"key":"392_CR121","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2006.04.014","volume":"23","author":"DF Emerich","year":"2006","unstructured":"Emerich DF, Thanos CG, Goddard M, Skinner SJM, Geany MS, Bell WJ, et al. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis. 2006;23:471\u201380.","journal-title":"Neurobiol Dis"},{"key":"392_CR122","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/154405910608500710","volume":"85","author":"D Kaigler","year":"2006","unstructured":"Kaigler D, Krebsbach PH, Wang Z, West ER, Horger K, Mooney DJ. Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res. 2006;85:633\u20137.","journal-title":"J Dent Res"},{"key":"392_CR123","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd1659","volume":"4","author":"TMS Chang","year":"2005","unstructured":"Chang TMS. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 2005;4:221\u201335.","journal-title":"Nat Rev Drug Discov"},{"key":"392_CR124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.bioeng.8.061505.095735","volume":"8","author":"VP Torchilin","year":"2006","unstructured":"Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng. 2006;8:343\u201375.","journal-title":"Annu Rev Biomed Eng"},{"key":"392_CR125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1471-4914(01)02088-3","volume":"7","author":"MB Chancellor","year":"2001","unstructured":"Chancellor MB, Yoshimura N, Pruchnic R, Huard J. Gene therapy strategies for urological dysfunction. Trends Mol Med. 2001;7:301\u20136.","journal-title":"Trends Mol Med"},{"key":"392_CR126","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1048-6666(01)80023-9","volume":"11","author":"N Adachi","year":"2001","unstructured":"Adachi N, Pelinkovic D, Lee CW, Fu FH, Huard J. Gene therapy and the future of cartilage repair. Oper Tech Orthop. 2001;11:138\u201344.","journal-title":"Oper Tech Orthop"},{"key":"392_CR127","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1359-6446(01)01810-4","volume":"6","author":"VJ Wright","year":"2001","unstructured":"Wright VJ, Peng HR, Huard J. Muscle-based gene therapy and tissue engineering for the musculoskeletal system. Drug Discov Today. 2001;6:728\u201333.","journal-title":"Drug Discov Today"},{"key":"392_CR128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jgm.344","volume":"5","author":"J Huard","year":"2003","unstructured":"Huard J, Li Y, Peng HR, Fu FH. Gene therapy and tissue engineering for sports medicine. J Gene Med. 2003;5:93\u2013108.","journal-title":"J Gene Med"},{"key":"392_CR129","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/ten.2007.0096","volume":"13","author":"N Kimelman","year":"2007","unstructured":"Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng. 2007;13:1135\u201350.","journal-title":"Tissue Eng"},{"key":"392_CR130","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1016\/j.biomaterials.2007.09.008","volume":"28","author":"A Usas","year":"2007","unstructured":"Usas A, Huard J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials. 2007;28:5401\u20136.","journal-title":"Biomaterials"},{"key":"392_CR131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1050-1738(01)00161-X","volume":"12","author":"T Sakai","year":"2002","unstructured":"Sakai T, Ling Y, Payne TR, Huard J. The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine. Trends Cardiovasc Med. 2002;12:115\u201320.","journal-title":"Trends Cardiovasc Med"},{"key":"392_CR132","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1016\/j.biomaterials.2006.05.021","volume":"27","author":"L Meinel","year":"2006","unstructured":"Meinel L, Hofmann S, Betz O, Fajardo R, Merkle HP, Langer R, et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials. 2006;27:4993\u20135002.","journal-title":"Biomaterials"},{"key":"392_CR133","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.biomaterials.2005.08.017","volume":"27","author":"H Hosseinkhani","year":"2006","unstructured":"Hosseinkhani H, Yamamoto M, Inatsugu Y, Hiraoka Y, Inoue S, Shimokawa H, et al. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. Biomaterials. 2006;27:1387\u201398.","journal-title":"Biomaterials"},{"key":"392_CR134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/109153601750124302","volume":"5","author":"S Tirney","year":"2001","unstructured":"Tirney S, Mattes CE, Yoshimura N, Yokayama T, Ozawa H, Tzeng E, et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol. 2001;5:37\u201343.","journal-title":"Mol Urol"},{"key":"392_CR135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.gt.3302515","volume":"12","author":"H Madry","year":"2005","unstructured":"Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K, et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther. 2005;12:1171\u20139.","journal-title":"Gene Ther"},{"key":"392_CR136","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.gt.3302396","volume":"12","author":"AJ Nixon","year":"2005","unstructured":"Nixon AJ, Haupt JL, Frisbie DD, Morisset SS, McIlwraith CW, Robbins PD, et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I\/interleukin-1 receptor antagonist therapy. Gene Ther. 2005;12:177\u201386.","journal-title":"Gene Ther"},{"key":"392_CR137","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.injury.2008.01.034","volume":"39","author":"AF Steinert","year":"2008","unstructured":"Steinert AF, N\u00f6th U, Tuan RS. Concepts in gene therapy for cartilage repair. Inj Int J Care Injured. 2008;39:S97\u2013S113.","journal-title":"Inj Int J Care Injured"},{"key":"392_CR138","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejpb.2007.04.021","volume":"68","author":"J Jo","year":"2008","unstructured":"Jo J, Tabata Y. Non-viral gene transfection technologies for genetic engineering of stem cells. Eur J Pharm Biopharm. 2008;68:90\u2013104.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0392-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-011-0392-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0392-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T10:04:27Z","timestamp":1560074667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-011-0392-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,19]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s11095-011-0392-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,19]]}}}